BioSpace News Archive

Press Releases

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio

October 9, 2024
·
19 min read
Business

C4 Therapeutics Announces Presentations and Participation in 7th Annual Targeted Protein Degradation & Induced Proximity Summit

October 9, 2024
·
2 min read
Press Releases

Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application for KT-621, a First-in-Class, Oral STAT6 Degrader

October 9, 2024
·
5 min read
Press Releases

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

October 9, 2024
·
3 min read
Press Releases

FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer

October 9, 2024
·
6 min read
Press Releases

Novavax’s Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU

October 9, 2024
·
8 min read
Press Releases

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

October 9, 2024
·
9 min read
Press Releases

Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4

October 9, 2024
·
1 min read
Press Releases

Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024

October 9, 2024
·
6 min read
Press Releases

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024

October 9, 2024
·
6 min read